Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Change in Acquisitions & Divestments (2019 - 2023)

Kodiak Sciences' (KOD) quarterly Change in Acquisitions & Divestments came in at $105.0 million in Q2 2023, down 55.32% on a QoQ basis from $235.0 million in Q1 2023.

Analysis

Kodiak Sciences (KOD) Change in Acquisitions & Divestments (2019 - 2023) Analysis & Trends

Kodiak Sciences (KOD) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $105.0 million in Q2 2023.

  • Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $105.0 million in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $105.0 million (down 71.85% YoY) and the FY2023 annual result came in at $340.0 million, up 146.38% from the prior year.
  • Change in Acquisitions & Divestments slipped to $105.0 million in Q2 2023, from $235.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $235.0 million in Q1 2023 to a low of -$2.4 million in Q4 2019.
  • A 5-year average of $58.6 million and a median of $57.4 million in 2020 frame the typical range for Change in Acquisitions & Divestments.
  • Annual changes were most pronounced in 2020 — Change in Acquisitions & Divestments jumped 2766.71% — and 2021, when it plunged 85.05%.
  • Tracing KOD's Change in Acquisitions & Divestments over 5 years: stood at -$2.4 million in 2019, then jumped by 2766.71% to $64.0 million in 2020, then plunged by 86.72% to $8.5 million in 2021, then soared by 747.06% to $72.0 million in 2022, then soared by 45.83% to $105.0 million in 2023.
  • The last three Change in Acquisitions & Divestments figures came in at $105.0 million (Q2 2023), $235.0 million (Q1 2023), and $72.0 million (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Kodiak Sciences 2.21 Bn 2.21 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 105.00 Mn
Mar 31, 2023 235.00 Mn
Dec 31, 2022 72.00 Mn
Sep 30, 2022 66.00 Mn
Jun 30, 2021 8.50 Mn
Mar 31, 2021 16.00 Mn
Dec 31, 2020 64.00 Mn
Sep 30, 2020 58.00 Mn
Jun 30, 2020 56.85 Mn
Mar 31, 2020 19.30 Mn
Dec 31, 2019 -2.40 Mn
Sep 30, 2019 4.80 Mn